Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 40

Results For "Inc"

7922 News Found

Johnson & Johnson brings India’s first PFA technology for atrial fibrillation treatment
Medical Device | June 03, 2026

Johnson & Johnson brings India’s first PFA technology for atrial fibrillation treatment

New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure


Akums secures European CEP approval for Cefpodoxime Proxetil
Drug Approval | June 03, 2026

Akums secures European CEP approval for Cefpodoxime Proxetil

The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner


FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence
R&D | June 03, 2026

FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence

A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India


Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types
Clinical Trials | June 03, 2026

Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types

The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials


Cipla launches India's first sputum inflammometry lab in Mumbai
Healthcare | June 03, 2026

Cipla launches India's first sputum inflammometry lab in Mumbai

The facility sets a new benchmark in respiratory diagnostics


Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept


Granules Pharmaceuticals receives USFDA EIR for Chantilly facility
News | June 03, 2026

Granules Pharmaceuticals receives USFDA EIR for Chantilly facility

This facility plays an important role in Granules’ global manufacturing and supply network


M|O|C Cancer Care’s research gains global recognition at ASCO 2026
Healthcare | June 02, 2026

M|O|C Cancer Care’s research gains global recognition at ASCO 2026

The accepted studies span several critical areas of oncology, including nutrition, genomics, precision medicine, patient-reported outcomes, and community-based cancer care


Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes
R&D | June 02, 2026

Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes

Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices